Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo

Blood

Volumn 99, Issue 12, 2002, Pages 4434-4442

  Byzova, Tatiana V ^a,b   Goldman, Corey K ^a,b   Jankau, Jurek ^a,b   Chen, Juhua ^a,b   Cabrera, Gustavo ^a,b   Achen, Marc G ^a,b   Stacker, Steven A ^a,b   Carnevale, Kevin A ^a,b   Siemionow, Maria ^a,b   Deitcher, Steven R ^a,b   DiCorleto, Paul E ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2;

ADENOVIRUS; ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CREMASTER MUSCLE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; TISSUE SPECIFICITY;

EID: 0037097816     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.12.4434     Document Type: Article

References (41)

1. The vascular endothelial growth factor family: Proteins which guide the development of the vasculature
2. Therapeutic angiogenesis for ischemic cardiovascular disease
3. Therapeutic angiogenesis: A case for targeted, regulated gene delivery
4. Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve
5. Vascular endothelial growth factor-C (VEGF-C/ VEGF-2) promotes angiogenesis in the setting of tissue ischemia
6. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
7. Angiogenesis gene therapy to rescue ischaemic tissues: Achievements and future directions
8. Molecular and biological properties of vascular endothelial growth factor
9. Lymphatic versus blood vascular endothelial growth factors and receptors in humans
10. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
11. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
12. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
13. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
14. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice
15. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin
16. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice
17. Vascular endothelial growth factor C induces angiogenesis in vivo
18. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D
19. Identification of a c-fos-induced gene that is related to the platelet- derived growth factor/vascular endothelial growth factor family
20. The specificity of receptor binding by vascular endothelial growth factor-D is different in mouse and man
21. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
22. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers
23. Proteolytic processing regulates receptor specificity and activity of VEGF-C
24. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice
25. c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro
26. 3 on vascular cells controls recognition of prothrombin
27. Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein
28. A mechanism for modulation of cellular responses to VEGF: Activation of the integrins
29. Introduction of cremaster muscle cnamber technique for long-term intravital microscopy
30. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′/kinase/Akt signal transduction pathway
31. Coexpression of flt-1, flt-4 and KDR in freshly isolated and cultured human endothelial cells
32. Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3
33. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
34. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing
35. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis
36. Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea
37. Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: Role of VEGF- receptor 2 and host VEGF-A
38. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
39. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
40. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease
41. Molecular regulation of lymphangiogenesis and targets for tissue oedema